Keck Hospital of USC — Los Angeles, California

Public research footprint of Keck Hospital of USC, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Familial Primary Pulmonary Hypertension · Non-Small Cell Lung Cancer · Breast Cancer · Unresectable Hepatocellular Carcinoma

Recently updated registry entries

NCT06080789 — A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants… (Recruiting)
NCT06120140 — Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor… (Active Not Recruiting)
NCT06664788 — A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Keck Hospital of USC?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.